[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:urothelial-carcinoma:tpm2-wt-allele":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Urothelial Carcinoma","TPM2 wt Allele",3,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07354100","Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:52.966503Z","2026-06-17T02:29:30.060269Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT04198766","Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)",[12],"2026-08-26T02:19:08.084946Z","2026-07-30T01:46:14.442744Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06349642","Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform",[],"2026-08-26T02:17:03.534765Z","2026-05-13T02:55:06.483978Z"]